Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps

Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps

Neutrophils through the release of neutrophil extracellular traps (NETs) containing active tissue factor (TF) are key components of thrombo-inflammation. Platelets-neutrophils interplay in ST elevation myocardial infarction (STEMI) promotes NET formation via inorganic polyphosphates (polyP) released...

Full description

Bibliographic Details
Main Authors:	Alexandros Mitsios, Akrivi Chrysanthopoulou, Athanasios Arampatzioglou, Iliana Angelidou, Veroniki Vidali, Konstantinos Ritis, Panagiotis Skendros, Dimitrios Stakos
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	neutrophil neutrophil extracellular traps inorganic polyphosphate thrombo-inflammation ticagrelor myocardial infraction
Online Access:	https://www.mdpi.com/1422-0067/21/10/3625

Similar Items

Methods for the Assessment of NET Formation: From Neutrophil Biology to Translational Research
by: Marina Stoimenou, et al.
Published: (2022-12-01)

Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps
by: Panagiotis Skendros, et al.
Published: (2018-09-01)

A gene expression map of host immune response in human brucellosis
by: Ioannis Mitroulis, et al.
Published: (2022-08-01)

The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients
by: Daniel Tobing, et al.
Published: (2019-09-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C
by: Shrey Kohli, et al.
Published: (2022-03-01)

Reacción de hipersensibilidad a ticagrelor
by: Jorge Alberto Castro Clavijo, et al.
Published: (2020-02-01)

Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis
by: Vitor H. Almeida, et al.
Published: (2019-07-01)

Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome
by: Vytenis Tamakauskas, et al.
Published: (2022-10-01)

A Case Report of Ticagrelor-Induced Thrombocytopenia
by: Alsalman M
Published: (2023-07-01)

The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome
by: Tamakauskas V, et al.
Published: (2024-01-01)

Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite
by: Shuaibing Liu, et al.
Published: (2021-10-01)

Ιnterleukin-17A-Enriched Neutrophil Extracellular Traps Promote Immunofibrotic Aspects of Childhood Asthma Exacerbation
by: Maria Ntinopoulou, et al.
Published: (2023-07-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Impact of Crystal Habit on Solubility of Ticagrelor
by: Yan Ren, et al.
Published: (2019-10-01)

Teofilina para o Alívio da Dispneia Relacionada ao Ticagrelor
by: Marcelo Sanmartin-Fernandez, et al.
Published: (2021-07-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study
by: Bibek Agarwal, et al.
Published: (2022-01-01)

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention
by: James C. Mamaril‐Davis, et al.
Published: (2021-11-01)

Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth.
by: Stella Arelaki, et al.
Published: (2016-01-01)

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide
by: Muhammad Inam, et al.
Published: (2018-08-01)

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01)

Plasticity of neutrophils reveals modulatory capacity
by: S.M. Perobelli, et al.
Published: (2015-08-01)

Plasticity of neutrophils reveals modulatory capacity
by: S.M. Perobelli, et al.
Published: (2015-06-01)

Ticagrelor regulates the differentiation of MDSCs after acute myocardial infarction to reduce cardiac injury
by: Zijian Huang, et al.
Published: (2024-03-01)

Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience
by: Vivek Karan, et al.
Published: (2019-09-01)

The effect of ticagrelor on ischemia-reperfusion injury of kidney: is the pleiotropic effect a valid factor?
by: Murat BAĞCIOĞLU, et al.
Published: (2017-08-01)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
by: Thomas W. Johnson, et al.
Published: (2020-12-01)

Prolonged ventricular pause associated with ticagrelor use: A case report
by: Alaa Rahhal, et al.
Published: (2021-10-01)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
by: Charalampos Papagoras, et al.
Published: (2022-08-01)

Successful Caesarean Section on Ticagrelor Treatment One Day after Primary Percutaneous Coronary Intervention
by: Nebojsa Antonijevic, et al.
Published: (2023-08-01)

Progress in the clinical effects and adverse reactions of ticagrelor
by: Peng Wei, et al.
Published: (2024-01-01)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Stylianos Petousis, et al.
Published: (2022-07-01)

The Effect of Ticagrelor for Endovascular Intervention of Intracranial Aneurysm Patients with or without Clopidogrel Resistant: A Meta-Analysis
by: Pengfei Xia, et al.
Published: (2022-08-01)

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01)

Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01)

A Case of Ticagrelor Resistance
by: Jahanzeb Malik
Published: (2021-07-01)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
by: Moazez J. Marian, et al.
Published: (2017-11-01)

The biochemistry of inorganic polyphosphates /
by: 244797 Kulaev, Igor S., et al.
Published: (2004)

Reversal of Platelet Inhibition in Patients Receiving Ticagrelor
by: Piotr Adamski, et al.
Published: (2022-09-01)